Akquisitionsfinanzierung

LatinFinance (2025 and 2026)

LatinFinance (2025)

Global Banking and Markets (2025)

LatinFinance Deals of the Year Awards (2025)

FactSet Flashwire Advisor Quarterly (H1 2026)

AvidXchange Holdings, a leading provider of accounts payable and payment automation solutions for the middle market, on its upsized initial public offering of its common stock at a price of $25.00 per share, with gross proceeds totaling $660 million.

BBVA, BNP Paribas, Citigroup, Goldman Sachs, J.P. Morgan, Natixis and Santander, as joint bookrunners in connection with Orygen’s issuance of $1.2 billion investment grade 5.746% senior notes due 2034. The team also advised the banks as lenders in a connected credit facility consisting of a $100 million term loan and $150 million revolving credit facility.

Goldman Sachs, BNP Paribas and Itaú Unibanco, in connection with CMA Terminal’s combined tag-along and delisting tender offer of Santos Brasil Participações S.A. The deal, valued at approximately $975 million, represents one of the largest transactions in Brazil in 2025.

Government of Jamaica and Montego Bay Airport Revenue Finance Limited, in connection with the securitization of Jamaica's rights to a portion of the revenues of the Montego Bay airport via Montego Bay Airport Revenue Finance Limited's $400 million 6.600% senior secured notes due 2035.

J.P. Morgan, Leerink Partners, Piper Sandler, and William Blair, as joint book-running managers in connection with CAMP4 Therapeutics Corporation’s (Nasdaq: CAMP) initial public offering.

J.P. Morgan and Oppenheimer & Co., as co-lead placement agents in Lexeo Therapeutics’ $80 million private placement.

J.P. Morgan Securities, Jefferies, Leerink, TD Cowen and Evercore as joint book-running managers in Kailera Therapeutics’ $625 million IPO.

Kyverna Therapeutics, a patient-centered clinical-stage biopharmaceutical company, in connection with its upsized IPO of 14,500,000 shares of common stock at an IPO price of $22.00 per share, for gross proceeds of approximately $319 million. In addition, Kyverna granted the underwriters a 30-day option to purchase up to an additional 2,175,000 shares of common stock at the IPO price.

Leerink Partners, Cantor, Stifel, Oppenheimer & Co. and Baird, in connection with Lexeo Therapeutics’ underwritten public offering. In addition, the firm advised Leerink Partners as placement agent in Lexeo’s concurrent private placement.

LG CNS, a leading Korean information technology service company and a member company of the LG Group, on its $823 million (KRW1.2 trillion) global offering and listing on the Korea Exchange.

SemiFive, a leading digital transformation-specialized company, on its $87.9 million global offering and listing on the KRX KOSDAQ Market of the Korea Exchange.

SHIFT UP, a leading game development studio in Korea, on its global offering and listing on the Korea Exchange. The shares were priced at KRW60,000 ($41.51) each, at the top end of the indicative range.

Smithfield and WH Group, a U.S. food company with a leading position in value-added packaged meats and fresh pork products, on the upsized $522 million sale of Smithfield common stock by SFDS UK Holdings Limited in a secondary offering with BofA Securities, Barclays and Morgan Stanley acting as joint lead book-running managers.

The financing sources providing committed financing for a $17.5 billion Reverse Morris Trust combination between Waters and BD’s (Becton, Dickinson and Company’s) Biosciences & Diagnostic Solutions business.

XTEND, a software-first defense technology company anchored by its AI XTEND Operating System, on its $1.5 billion business combination with JFB Construction Holdings, a real estate development and construction company.